Interview with Jan-Willem Eleveld, Vice President, Counsulting & Services,…
You spent most of your career in the pharmaceutical industry with Bristol Meyers Squibb and earlier on for NV Organon which you joined in 1998. In 2007 you left to…
Address: 302, Level 3, Damansara Uptown 2, 2 Jalan SS21/37, 47400 Petaling Jaya, Selangor,Malaysia
Tel: 603 7710 7380
Web: http://www.imshealth.com/portal/site/ims
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. We offer a variety of solutions to help clients understand the marketplace, improve marketing effectiveness and optimize sales productivity. With a presence in more than 100 countries and over 55 years of experience, IMS applies leading-edge technologies to transform billions of pharmaceutical transactions collected from thousands of sources into strategic insights. Interpreted and analyzed by IMS experts, these insights are an unmatched source of trends and perspectives about the pharmaceutical marketplace – precise market intelligence that can be translated into action.
Commercial Implementation Services: We help meet the challenges of commercial information management, with cutting-edge solutions in reporting and analytics, and operations and compensation outsourcing.
Managed Markets Services: With more than three-quarters of U.S. prescriptions underwritten by third-party payers, we’re the ones to call to help meet contracting, compliance and systems challenges.
Market Research Services: We not only deliver views of market position, but also provide related services — including outsourcing of key market research processes.
We apply Evidence-Based ConsultingSM that can have an immediate impact on the business and market performance of our clients. We help to strengthen portfolios, optimize product launches, mount superior marketing efforts, forge more productive alliances and optimize sales force structure and deployment.
Product & Portfolio Strategy
Companies that don’t plan for the future don’t have one. We help keep the compass pointed in the right direction.
Commercial Effectiveness
A surprisingly low percentage of pharmaceutical brands outperform expectations. We help clients gain access to that elite club.
Pricing & Market Access
There’s both an art and a science to launching new products and ensuring optimal market access and price. We understand the complex dynamics shaping the prospects for products in research and development as well as for those already in-market.
You spent most of your career in the pharmaceutical industry with Bristol Meyers Squibb and earlier on for NV Organon which you joined in 1998. In 2007 you left to…
The Pharmaceutical Services Division has been around since 1951, what have been the major shifts in its objectives since then? When the pharmacy service came into existence in this country…
One of the key factors for the growth in the pharmaceutical market has been the increasing professionalism of healthcare in Malaysia. How does the MMA contribute to the professionalism of…
Would you give our readers an insight into the government’s attempts to foster a better environment for FDI in Malaysia? Over the last year, the significant development has been the…
Before joining Nycomed you spent a year working at the Drug Control Authority (DCA). What did your regulatory friends say when you told them you were off to join the…
When we spoke to Herbert Dittmar of Bayer, he said that there were no specific challenges in Malaysia that could not be found elsewhere. How do you convince companies of…
Can you give our readers an outline of Bayer’s background in Malaysia and its current organisational division? Herbert Dittmar (HD): Bayer has been in Malaysia for around fifty years. It…
Kebangsaan Malaysia (UKM). Singapore and Taiwan are known for their high level of basic research and their focus on Biotechnology. Philip Yeo, Chairman of Spring Singapore told us that Biomedical…
Nowadays we can talk of an abundance of information coming from companies like Frost& Sullivan, IMS and even consultancies who are producing their own data. As a leader in market…
You have worked in the pharmaceutical industry for many years starting with Novartis and you have spent the last eight years working for Lundbeck. What are the major changes that…
Pharmaceutical Executive is a magazine about executives, their experience and their perspectives on the pharmaceutical industry. You have worked in Australia, Hong Kong and now you are the general manager…
You spent most of your career in the pharmaceutical industry with Bristol Meyers Squibb and earlier on for NV Organon which you joined in 1998. In 2007 you left to…
You have spent much of your time working in the USA and came to Malaysia in 2008 as Country Manager. What were your expectations of Malaysia before you arrived and…
See our Cookie Privacy Policy Here
